Vitamins and supplements
Multivitamins and minerals, in any combination
Vitamin and mineral combinations
Other names: ComBgen, Os-Cal, Theragran-M, Nephro-Vite, multivitamin, cyanocobalamin (vitamin B12)
FAA guidance
Acceptable in the FAA document cited.
The FAA's MedGuide lists any combination of multivitamin, cyanocobalamin (vitamin B12), folic acid (vitamin B9), biotin (vitamin B7), pyridoxine (vitamin B6), thiamine (vitamin B1), vitamin C, minerals, magnesium, calcium carbonate and calcium citrate (ComBgen, Os-Cal, Theragran-M, Nephro-Vite) as allowed, for supplement, with no wait after the first dose, after later doses or after the final dose, used per label directions.
Track your medicationsMore detail: Multivitamins and minerals, in any combinationThe rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
Show the FAA's words: Multivitamins and minerals, in any combinationThe official FAA wording: three passages, each with its document and dateOpen
Generic: Any combination of: multivitamin; cyanocobalamin (vitamin B12); folic acid (vitamin B9); biotin (vitamin B7); pyridoxine (vitamin B6); thiamine (vitamin B1); vitamin C; minerals; magnesium; calcium carbonate; calcium citrate
Brand Name: ComBgen; Os-Cal; Theragran-M; Nephro-Vite
Drug Class: Vitamin and mineral combinations
Underlying Condition: Supplement
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.